TY - JOUR AU - Cosmin Caraiani AU - Anamaria Pop AU - Adriana Calin AU - Lidia Ciobanu AU - Claudia Militaru AU - Alexandra Berghe AU - Radu Badea PY - 2018/07/24 Y2 - 2024/03/29 TI - Incidental findings during follow-up scans in oncological patients JF - Medicine and Pharmacy Reports JA - Medicine and Pharmacy Reports VL - 91 IS - 3 SE - Original Research DO - 10.15386/cjmed-931 UR - https://medpharmareports.com/index.php/mpr/article/view/931 AB - Background and aim. To assess the prevalence of incidental findings during follow-up scans of patients with oncologic pathology.Methods. 499 follow-up scans from different patients with cancer pathology were retrospectively analyzed. Findings which were not suspected by the clinician or known from previous scans were considered as incidental lesions. We excluded lesions that were already suspected by the clinician or were already recorded in the patient’s history before the initial computed tomography (CT) scan. The CT scans were performed on two different machines (“Siemens Somatom Sensation, 64 slices, Erlangen, Germany” and “Siemens Somatom Emotion, 16 slices, Erlangen, Germany”).Most of the patients had a native scan followed by a thoraco-abdominal-pelvic image acquisition after the injection of intravenous contrast media.Results. 28% of the patients had unsuspected incidental findings. The prevalence of incidental findings was similar: 56.6% of them were found in men and 43.4% in female patients. In 6 cases (1.2%) the presence of unsuspected pulmonary embolism was discovered. From these cases, 5 (83.3%) had metastatic disease at the moment of the follow-up CT scan and 1 (16.6%) had metastasis-free disease. In 17 patients out of 499 (3.4%) we incidentally made an important discovery which either changed the cancer therapy or required immediate treatment.Conclusion. Incidental findings are not rare in oncological patients and the radiologist has to be aware of their presence in order not to overlook them and to correctly diagnose them. ER -